Mifepristone Tablets (For Ending Early Pregnancy) and Recombinate
Determining the interaction of Mifepristone Tablets (For Ending Early Pregnancy) and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mifepristone
Brand name: Korlym, Mifeprex
Synonyms: Mifepristone
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mifepristone Tablets (For Ending Early Pregnancy)-Recombinate recombinant
- Mifepristone Tablets (For Ending Early Pregnancy)-Recombivax
- Mifepristone Tablets (For Ending Early Pregnancy)-Recombivax HB
- Mifepristone Tablets (For Ending Early Pregnancy)-Recombivax HB Adult
- Mifepristone Tablets (For Ending Early Pregnancy)-Recombivax HB Dialysis Formulation
- Mifepristone Tablets (For Ending Early Pregnancy)-Recombivax HB Pediatric/Adolescent
- Recombinate-Mifepristone Tablets (For High Blood Sugar)
- Recombinate-Migalastat
- Recombinate-Migalastat Hydrochloride
- Recombinate-Migergot
- Recombinate-Migergot Suppository
- Recombinate-Miglitol